Arginine Therapy for Lung Diseases
Nitric oxide (NO) is produced by a family of isoenzymes, nitric oxide synthases (NOSs), which all utilize L-arginine as substrate. The production of NO in the lung and airways can play a number of roles during lung development, regulates airway and vascular smooth muscle tone, and is involved in inf...
Main Authors: | Jeremy A. Scott, Harm Maarsingh, Fernando Holguin, Hartmut Grasemann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.627503/full |
Similar Items
-
The clinical features of the overlap between COPD and asthma
by: Schroeder Joyce D, et al.
Published: (2011-09-01) -
The Role of Zinc in the Pathogenesis of Lung Disease
by: Xiaoying Liu, et al.
Published: (2022-05-01) -
Lactoferrin Ameliorates Ovalbumin-Induced Asthma in Mice through Reducing Dendritic-Cell-Derived Th2 Cell Responses
by: Chi-Chien Lin, et al.
Published: (2022-11-01) -
Pericytes: The lung-forgotten cell type
by: Annelise T. Garrison, et al.
Published: (2023-03-01) -
Cigarette smoke aggravates asthma via altering airways inflammation phenotypes and remodelling
by: Qiong Huang, et al.
Published: (2023-12-01)